Key facts
- This page summarizes Robert A. Ortenzio's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2023, 17:40.
Robert A. Ortenzio - 08 Aug 2023 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)
- Reporting relationship
- EXECUTIVE CHAIRMAN, Director
- Issuer ticker
- SEM
- Reported as of
- 08 Aug 2023
- Net transaction value
- -$1,476,000
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2023, 17:40:55 UTC
- Prior SEC filing
- 02 Aug 2023
- Next SEC filing
- 11 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael E. Tarvin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert A. Ortenzio filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 09 Aug 2023.
Change
- Previous filing in this sequence was filed on 02 Aug 2023.
- Current net transaction value: -$1,476,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SEM
transaction
Common Stock
Sale
- Transaction value
- $1,476,000
- Shares
- -50,000
- Change %
- -0.7%
- Price
- $29.52
- Shares after
- 7,089,668
- Date
- 08 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2
SEM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,279,000
- Date
- 08 Aug 2023
- Ownership
- By the Robert A. Ortenzio Descendants Trust
- Footnotes
- F3
SEM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,804,805
- Date
- 08 Aug 2023
- Ownership
- By the Rocco A. Ortenzio Separate Exempt Descendants Trust
- Footnotes
- F3
SEM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 280,415
- Date
- 08 Aug 2023
- Ownership
- By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio
- Footnotes
- F3
SEM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 280,415
- Date
- 08 Aug 2023
- Ownership
- By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio
- Footnotes
- F3
SEM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 280,415
- Date
- 08 Aug 2023
- Ownership
- By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.355 to $30.035, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
Footnote F3
The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.